SRTS241220P7000
- 0.25
- 0.000.00%
Sensus Healthcare Newsroom
Sensus Healthcare (NASDAQ:SRTS) Knows How To Allocate Capital Effectively
H.C. Wainwright Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Raises Target Price to $11
Express News | HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $11
Express News | Revised - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More Than Doubling Versus 2023 Third Quarter
Press Release: REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More Than Doubling Versus 2023 Third Quarter
Sensus Healthcare Analyst Ratings
Maxim Group Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Raises Target Price to $14
Roth MKM Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Maintains Target Price $10
Roth MKM Keeps Their Buy Rating on Sensus Healthcare (SRTS)
Sensus Healthcare Price Target Raised to $14 From $12 at Maxim
Sensus Healthcare, Inc. (SRTS) Q3 2024 Earnings Call Transcript Summary
Sensus Healthcare GAAP EPS of $0.07 Beats by $0.08, Revenue of $8.84M Beats by $2.94M
Sensus Healthcare, Inc. (SRTS) Surpasses Q3 Earnings and Revenue Estimates
Sensus Healthcare | 10-Q: Q3 2024 Earnings Report
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q3 Revenue $8.8M
Express News | Sensus Healthcare Q3 Revenue USD 8.839 Million
Express News | Sensus Healthcare Q3 Basic EPS USD 0.07
Express News | Sensus Healthcare Q3 Operating Expenses USD 3.745 Million
Express News | Sensus Healthcare Q3 Net Income USD 1.215 Million
Express News | Sensus Healthcare Q3 Adjusted Ebitda USD 1.593 Million